NIAID Banner Logo Image

HIV Citation List: November 24 - December 9, 2010

Pubmed citations:

1. Multidrug resistance reversal properties and cytotoxic evaluation of representatives of a novel class of HIV-1 protease inhibitors. Coburger, C., H. Lage, J. Molnar, A. Langner, and A. Hilgeroth. Journal of Pharmacy and Pharmacology, 2010. 62(12): p. 1704-10; PMID[21054396].

[Pubmed]. HIV_1124-121010.

2. The Formulated Microbicide RC-101 Was Safe and Antivirally Active Following Intravaginal Application in Pigtailed Macaques. Cole, A.M., D.L. Patton, L.C. Rohan, A.L. Cole, Y. Cosgrove-Sweeney, N.A. Rogers, D. Ratner, A.B. Sassi, C. Lackman-Smith, P. Tarwater, B. Ramratnam, P. Ruchala, R.I. Lehrer, A.J. Waring, and P. Gupta. PLoS One, 2010. 5(11): p. e15111; PMID[21124745].

[Pubmed]. HIV_1124-121010.

3. Suppression of HIV-1 transcriptional elongation by a DING phosphatase Darbinian, N., R. Gomberg, L. Mullen, S. Garcia, M.K. White, K. Khalili, and S. Amini. Journal of Cellular Biochemistry, 2010. [Epub ahead of print]; PMID[21117063].

[Pubmed], HIV_1124-121010.

4. Design and Synthesis of alpha-Carboxy Phosphononucleosides. Debarge, S., J. Balzarini, and A.R. Maguire. Journal of Organic Chemistry, 2010. [Epub ahead of print]; PMID[21121618].

[Pubmed].HIV_1124-121010.

5. Inhibition of HIV-1 by Fusion Inhibitors. Eggink, D., B. Berkhout, and R.W. Sanders. Current Pharmaceutical Design, 2010. [Epub ahead of print]; PMID[21128887].

[Pubmed].HIV_1124-121010.

6. New insights into the mechanisms whereby low molecular weight CCR5 ligands inhibit HIV-1 infection. Garcia-Perez, J., P. Rueda, I. Staropoli, E. Kellenberger, J. Alcami, F. Arenzana-Seisdedos, and B. Lagane. Journal of Biological Chemistry, 2010. [Epub ahead of print]; PMID[21118814].

[Pubmed].HIV_1124-121010.

7. Interaction of HIV-1 Reverse Transcriptase Ribonuclease H with an Acylhydrazone Inhibitor. Gong, Q., L. Menon, T. Ilina, L.G. Miller, J. Ahn, M.A. Parniak, and R. Ishima. Chemical Biology & Drug Design, 2011. 77(1): p. 39-47; PMID[21114787].

[Pubmed].HIV_1124-121010.

8. Alkylated Porphyrins Have Broad Antiviral Activity against Hepadnaviuses, Flaviviruses, Filoviruses and Arenaviruses. Guo, H., X. Pan, R. Mao, X. Zhang, L. Wang, X. Lu, J. Chang, J.T. Guo, S. Passic, F.C. Krebs, B. Wigdahl, T.K. Warren, C.J. Retterer, S. Bavari, X. Xu, A. Cuconati, and T.M. Block. Antimicrobial Agents and Chemotherapy, 2010. [Epub ahead of print]; PMID[21135183].

[Pubmed].HIV_1124-121010.

9. Cyclic peptide inhibitors of HIV-1 integrase derived from the LEDGF/p75 protein. Hayouka, Z., M. Hurevich, A. Levin, H. Benyamini, A. Iosub, M. Maes, D.E. Shalev, A. Loyter, C. Gilon, and A. Friedler. Bioorganic & Medicinal Chemistry, 2010. 18(23): p. 8388-95; PMID[20974536].

[Pubmed].HIV_1124-121010.

10. C-C chemokine receptor type 5 (CCR5) utilization of transmitted and early founder human immunodeficiency virus type 1 envelopes and sensitivity to small-molecule CCR5 inhibitors. Hu, Q., X. Huang, and R.J. Shattock. Journal of General Virology, 2010. 91(Pt 12): p. 2965-73; PMID[20810746].

[Pubmed].HIV_1124-121010.

11. The evaluation of catechins that contain a galloyl moiety as potential HIV-1 integrase inhibitors. Jiang, F., W. Chen, K. Yi, Z. Wu, Y. Si, W. Han, and Y. Zhao. Clinical Immunology, 2010. 137(3): p. 347-56; PMID[20832370].

[Pubmed].HIV_1124-121010.

12. New Therapeutic Approaches Targeted at the Late Stages of the HIV-1 Replication Cycle. Jiang, Y., X. Liu, and E. De Clercq. Current Medicinal Chemistry, 2010. [Epub ahead of print]; PMID[21110817].

[Pubmed].HIV_1124-121010.

13. Immunoregulatory and anti-HIV-1 enzyme activities of antioxidant components from lotus (Nelumbo nucifera Gaertn) rhizome. Jiang, Y., T.B. Ng, Z. Liu, C. Wang, N. Li, W. Qiao, and F. Liu. Bioscience Reports, 2010. [Epub ahead of print]; PMID[21114474].

[Pubmed].HIV_1124-121010.

14. Triplex-forming MicroRNAs form stable complexes with HIV-1 provirus and inhibit its replication. Kanak, M., M. Alseiari, P. Balasubramanian, K. Addanki, M. Aggarwal, S. Noorali, A. Kalsum, K. Mahalingam, G. Pace, N. Panasik, and O. Bagasra. Applied Immunohistochemistry Molecular Morphology, 2010. 18(6): p. 532-45; PMID[20502318].

[Pubmed].HIV_1124-121010.

15. Discovery of a small molecule PDI inhibitor that inhibits reduction of HIV-1 envelope glycoprotein gp120. Khan, M.M., S. Siro, S. Lai, M. Kawatani, T. Shimizu, and H. Osada. ACS Chemical Biology, 2010. [Epub ahead of print]; PMID[21121641].

[Pubmed].HIV_1124-121010.

16. In Vitro Virology of S/GSK1349572, a Next-Generation HIV Integrase Inhibitor. Kobayashi, M., T. Yoshinaga, T. Seki, C. Wakasa-Morimoto, K.W. Brown, R. Ferris, S.A. Foster, R.J. Hazen, S. Miki, A. Suyama-Kagitani, S. Kawauchi-Miki, T. Taishi, T. Kawasuji, B.A. Johns, M.R. Underwood, E.P. Garvey, A. Sato, and T. Fujiwara. Antimicrobial Agents and Chemotherapy, 2010. [Epub ahead of print]; PMID[21115794].

[Pubmed].HIV_1124-121010.

17. EASY-HIT: HIV full-replication technology for broad discovery of multiple classes of HIV inhibitors. Kremb, S., M. Helfer, W. Heller, D. Hoffmann, H. Wolff, A. Kleinschmidt, S. Cepok, B. Hemmer, J. Durner, and R. Brack-Werner. Antimicrobial Agents and Chemotherapy, 2010. 54(12): p. 5257-68; PMID[20876377].

[Pubmed].HIV_1124-121010.

18. Anti-HIV-1 activity of the neurokinin-1 receptor antagonist aprepitant and synergistic interactions with other antiretrovirals. Manak, M.M., D.A. Moshkoff, L.T. Nguyen, J. Meshki, P. Tebas, F. Tuluc, and S.D. Douglas. AIDS, 2010. 24(18): p. 2789-96; PMID[20975512].

[Pubmed].HIV_1124-121010.

19. Excessive RNA Splicing and Inhibition of HIV-1 Replication Induced by Modified U1 Small Nuclear RNAs. Mandal, D., Z. Feng, and C.M. Stoltzfus. Journal of Virology, 2010. 84(24): p. 12790-800; PMID[20926575].

[Pubmed].HIV_1124-121010.

20. Small-molecule inactivation of HIV-1 NCp7 by repetitive intracellular acyl transfer. Miller Jenkins, L.M., D.E. Ott, R. Hayashi, L.V. Coren, D. Wang, Q. Xu, M.L. Schito, J.K. Inman, D.H. Appella, and E. Appella. Natural Chemical Biology, 2010. 6(12): p. 887-9; PMID[20953192].

[Pubmed].HIV_1124-121010.

21. Protection of HIV-neutralizing aptamers against rectal and vaginal nucleases: implications for RNA-based therapeutics. Moore, M.D., J. Cookson, V.K. Coventry, B. Sproat, L. Rabe, R.D. Cranston, I. McGowan, and W. James. Journal of Biological Chemistry, 2010. [Epub ahead of print]; PMID[21106536].

[Pubmed].HIV_1124-121010.

22. 1-Benzyl derivatives of 5-(arylamino)uracils as anti-HIV-1 and anti-EBV agents. Novikov, M.S., R.W. Buckheit, Jr., K. Temburnikar, A.L. Khandazhinskaya, A.V. Ivanov, and K.L. Seley-Radtke. Bioorganic & Medicinal Chemistry, 2010. 18(23): p. 8310-4; PMID[21035347].

[Pubmed].HIV_1124-121010.

23. Analyses of nanoformulated antiretroviral drug charge, size, shape and content for uptake, drug release and antiviral activities in human monocyte-derived macrophages. Nowacek, A.S., S. Balkundi, J. McMillan, U. Roy, A. Martinez-Skinner, R.L. Mosley, G. Kanmogne, A.V. Kabanov, T. Bronich, and H.E. Gendelman. Journal of Controlled Release, 2010. [Epub ahead of print]; PMID[21108978].

[Pubmed].HIV_1124-121010.

24. Structure-activity relationships of polybiguanides with activity against human immunodeficiency virus type 1. Passic, S.R., M.L. Ferguson, B.J. Catalone, T. Kish-Catalone, V. Kholodovych, W. Zhu, W. Welsh, R. Rando, M.K. Howett, B. Wigdahl, M. Labib, and F.C. Krebs. Biomedicine and Pharmacotherapy, 2010. 64(10): p. 723-32; PMID[21106331].

[Pubmed].HIV_1124-121010.

25. Antiretroviral Activity of Thiosemicarbazone Metal Complexes. Pelosi, G., F. Bisceglie, F. Bignami, P. Ronzi, P. Schiavone, M.C. Re, C. Casoli, and E. Pilotti. Journal of Medicinal Chemistry, 2010. [Epub ahead of print]; PMID[21121632].

[Pubmed].HIV_1124-121010.

26. Protective effect of partially purified 35 kDa protein from silk worm (Bombyx mori) fecal matter against carbon tetrachloride induced hepatotoxicity and in vitro anti-viral properties. Raghavendra, R., S. Neelagund, G. Kuluvar, V. Bhanuprakash, and Y. Revanaiah. Pharmaceutical Biology, 2010. 48(12): p. 1426-31; PMID[20738178].

[Pubmed].HIV_1124-121010.

27. An Imidazopiperidine Series of CCR5 Antagonists for the Treatment of HIV: The Discovery of N-{(1S)-1-(3-Fluorophenyl)-3-[(3-endo)-3-(5-isobutyryl-2-methyl-4,5,6,7-tetrahydr o-1H-imidazo[4,5-c], Pubmed, HIV_1124-121010.pyridin-1-yl)-8-azabicyclo[3.2.1], Pubmed, HIV_1124-121010.oct-8-yl], Pubmed, HIV_1124-121010.propyl}acetamide (PF-232798). Stupple, P.A., D.V. Batchelor, M. Corless, P.K. Dorr, D. Ellis, D.R. Fenwick, S.R. Galan, R.M. Jones, H.J. Mason, D.S. Middleton, M. Perros, F. Perruccio, M.Y. Platts, D.C. Pryde, D. Rodrigues, N.N. Smith, P.T. Stephenson, R. Webster, M. Westby, and A. Wood. Journal of Medicinal Chemistry, 2010. [Epub ahead of print]; PMID[21128663].

[Pubmed].HIV_1124-121010.

28. Functional Roles of Azoles Motif in Anti-HIV Agents. Zhan, P., D. Li, X. Chen, X. Liu, and E. De Clercq. Current Medicinal Chemistry, 2010. [Epub ahead of print]; PMID[21110816].

[Pubmed].HIV_1124-121010.

ISI Web of Knowledge citations:

29. High-Affinity Glycopolymer Binding to Human DC-SIGN and Disruption of DC-SIGN Interactions with HIV Envelope Glycoprotein. Becer, C.R., M.I. Gibson, J. Geng, R. Ilyas, R. Wallis, D.A. Mitchell, and D.M. Haddleton. Journal of the American Chemical Society, 2010. 132(43): p. 15130-15132; ISI[000283621700012].

[WOS]. HIV_1124-121010.

30. A cardiac glucoside with invitro anti-HIV activity isolated from Elaeodendron croceum. Prinsloo, G., J.J.M. Meyer, A.A. Hussein, E. Munoz, and R. Sanchez. Natural Product Research, 2010. 24(18): p. 1743-1746; ISI[000283687900010].

[WOS]. HIV_1124-121010.

31. Diastereoselective Synthesis of Aryloxy Phosphoramidate Prodrugs of 3 '-Deoxy-2 ',3 '-didehydrothymidine Monophosphate. Roman, C.A., J. Balzarini, and C. Meier. Journal of Medicinal Chemistry, 2010. 53(21): p. 7675-7681; ISI[000283703000016].

[WOS]. HIV_1124-121010.

32. Microwave-Assisted Synthesis of Some Novel Thiazolidinone and Thiohydantoin Derivatives of Isatins. Raghuvanshi, D.S. and K.N. Singh. Phosphorus Sulfur and Silicon and the Related Elements, 2010. 185(11): p. 2243-2248; ISI[000283882100010].

[WOS]. HIV_1124-121010.

33. Synthesis and bioactivity of erythro-nordihydroguaiaretic acid, threo-(-)-saururenin and their analogues. Xia, Y.M., Y.Y. Zhang, W. Wang, Y.N. Ding, and R. He. Journal of the Serbian Chemical Society, 2010. 75(10): p. 1325-1335; ISI[000283895200002].

[WOS]. HIV_1124-121010.

34. Four New Nortriterpenoids from Schisandra lancifolia. Xiao, W.L., Y.L. Wu, S.Z. Shang, F. He, X.A. Luo, G.Y. Yang, J.X. Pu, G.Q. Chen, and H.D. Sun. Helvetica Chimica Acta, 2010. 93(10): p. 1975-1982; ISI[000283908200012].

[WOS]. HIV_1124-121010.

35. Amino acid derivatives. Part 6. New analogs of the angiotensin-converting enzyme 'Captopril'. Synthesis and anti-HIV activity. Al-Masoudi, N.A., N.S. Hamad, S. Hameed, and C. Pannecouque. Arkivoc, 2010: p. 242-253; ISI[000284104800020].

[WOS]. HIV_1124-121010.

36. Antiretroviral activity of two polyisoprenylated acylphloroglucinols, 7-epi-nemorosone and plukenetione A, isolated from Caribbean propolis. Diaz-Carballo, D., K. Ueberla, V. Kleff, S. Ergun, S. Malak, M. Freistuehler, S. Somogyi, C. Kucherer, W. Bardenheuer, and D. Strumberg. International Journal of Clinical Pharmacology and Therapeutics, 2010. 48(10): p. 670-677; ISI[000284131200005].

[WOS]. HIV_1124-121010.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: May 2021